sar
group
includ
male
femal
mean
age
year
rang
year
nonsar
group
includ
male
femal
mean
age
year
rang
year
serum
sampl
sar
nonsar
group
repres
first
time
point
hospit
day
onset
fever
medic
includ
steroid
ribavirin
tradit
chines
medicin
intraven
immunoglobulin
given
patient
blood
collect
sar
case
posit
antisarscov
igg
antibodi
serolog
test
antisarscov
igg
antibodi
detect
indirect
immunofluoresc
assay
use
vero
cell
infect
strain
cov
genbank
access
isol
patient
sar
sensit
specif
serolog
test
sar
serum
sarscov
rna
test
perform
patient
show
detect
sarscov
rna
serum
control
group
nonsar
patient
bacteri
pneumonia
aspiratori
pneumonia
acut
pulmonari
edema
upper
respiratori
tract
infect
influenza
acut
bronchiti
bronchiectasi
secondari
lung
cancer
gastrointestin
bleed
acut
cholang
infecti
mononucleosi
viral
gastroenter
liver
abscess
periton
end
stage
renal
failur
cellulit
thalam
hemorrhag
symptom
similar
sar
patient
admit
hospit
sar
patient
later
shown
neg
sarscov
antibodi
serolog
test
least
week
onset
symptom
biochem
inform
collect
blood
sampl
sampl
store
aliquot
proteinchip
array
profil
analysi
perform
seldi
proteinchip
analysi
serum
sampl
diseas
control
group
random
investig
blind
ident
seldi
proteinchip
analysi
perform
describ
previous
set
bind
condit
sampl
analyz
duplic
serum
sampl
denatur
addit
buffer
moll
urea
gl
chap
mmoll
trishcl
ph
incub
ice
min
denatur
serum
sampl
dilut
mmoll
sodium
acet
mll
triton
ph
mmoll
tri
mll
triton
ph
bind
buffer
respect
give
final
dilut
proteinchip
array
ciphergen
biosystem
use
studi
dilut
dilut
sampl
appli
preequilibr
proteinchip
array
duplic
bioprocessor
incub
shake
min
room
temperatur
incub
proteinchip
array
wash
time
bind
buffer
rins
twice
deioniz
water
airdri
sinapin
acid
matrix
mll
mll
trifluoroacet
acid
ad
array
proteinchip
array
read
proteinchip
pb
ii
reader
proteinchip
biomark
system
ciphergen
biosystem
determin
mass
intens
peak
rang
mz
box
piec
contain
assay
spot
proteinchip
array
array
assay
spot
use
calibr
mixtur
peptideprotein
calibr
angiotensin
mz
corticotropin
clip
mz
corticotropin
clip
mz
doubli
charg
hors
apomyoglobin
mz
escherichia
coli
thioredoxin
mz
hors
apomyoglobin
mz
bovin
serum
albumin
mz
bovin
serum
albumin
dimer
mz
appli
biosystem
ltd
ad
assay
spot
calibr
array
intens
peak
mz
obtain
laser
set
optim
rang
mz
intens
peak
mz
obtain
laser
set
optim
rang
mz
spectra
smooth
baselinesubtract
extern
calibr
common
peak
among
seldi
mass
spectra
identifi
quantifi
use
biomark
wizard
softwar
ciphergen
biosystem
peak
intens
normal
total
ion
current
subsequ
total
peak
intens
data
mine
normal
peak
intens
duplic
measur
averag
intraassay
cv
normal
intens
variou
peak
identifi
proteom
featur
associ
diseas
use
criteria
normal
peak
intens
significantli
higherlow
sar
patient
nonsar
individu
b
normal
peak
intens
correl
clinicalbiochem
variabl
indic
biolog
meaning
signific
analysi
microarray
sam
algorithm
stanford
univers
use
identifi
proteom
featur
concentr
significantli
differ
sar
nonsar
patient
group
sam
analysi
two
class
unpair
data
select
data
type
permut
perform
fals
signific
discoveri
rate
set
zero
avoid
identif
fals
signific
proteom
featur
caus
multipl
comparison
correl
differenti
proteom
featur
variou
clinicalbiochem
featur
examin
spearman
rankord
correl
test
signific
differenti
proteom
featur
correl
variou
clinicalbiochem
correl
subject
twoway
hierarch
cluster
analysi
describ
previous
cluster
analysi
data
proteom
featur
subject
zeromean
unitvari
normal
process
proteom
data
serum
sampl
subject
twoway
hierarch
cluster
analysi
cluster
treeview
spearman
rank
correl
use
calcul
distanc
complet
linkag
cluster
perform
protein
identif
protein
correspond
sedli
peak
purifi
cationexchang
chromatographi
use
ceram
bead
biosepra
bind
condit
similar
proteinchip
array
briefli
pool
serum
sampl
first
denatur
buffer
dilut
sampl
bind
buffer
respect
incub
min
subsequ
wash
bound
protein
elut
ceram
bead
moll
nacl
solut
ziptip
use
desalt
elut
protein
accord
manufactur
instruct
millipor
desalt
protein
prepar
spot
goldcoat
proteinchip
array
examin
proteinchip
reader
confirm
purifi
protein
mass
target
sedli
proteom
featur
confirm
purifi
protein
resolv
gel
electrophoresi
absenc
reduc
agent
protein
gel
visual
either
colloid
blue
invitrogentrad
silver
stain
ge
healthcar
gel
imag
digit
densitomet
analyz
pdquest
gel
analysi
softwar
ver
biorad
protein
spot
mass
match
differenti
proteom
featur
excis
subject
mass
spectrometr
ms
analysi
protein
spot
interest
remov
gel
subject
trypsin
digest
describ
previous
trypsin
digest
extract
subject
tandem
ms
msm
analysi
abi
system
appli
biosystem
trypsin
peak
possibl
keratin
contamin
matrix
cluster
peak
exclud
subsequ
collisioninduc
dissoci
msm
spectra
process
data
explor
softwar
ver
appli
biosystem
spectra
subject
gaussian
smooth
filter
width
point
baselin
correct
default
set
peak
detect
base
signaltonois
threshold
fragment
mass
intens
msm
mass
spectrum
subject
onlin
mascot
msm
ion
search
http
wwwmatrixsciencecom
obtain
protein
ident
search
paramet
maximum
allow
miss
cleavag
trypsin
digest
partial
oxid
methionin
phosphoryl
serinethreoninetyrosin
iodoacetamid
modif
cystein
residu
select
error
toler
valu
parent
peptid
msm
ion
mass
da
respect
protein
identif
result
consid
signific
msm
ion
profil
match
known
protein
ncbinr
databas
p
valu
identifi
protein
access
number
uniprot
protein
databas
ver
report
avail
common
proteom
featur
identifi
compar
sar
nonsar
patient
group
use
sam
median
fals
discoveri
rate
zero
identifi
proteom
featur
significantli
differenti
express
group
fiftytwo
increas
decreas
sar
group
avoid
identif
fals
signific
proteom
featur
caus
systemat
bia
consid
differenti
proteom
featur
fig
tabl
significantli
correl
least
biochemicalclin
variabl
sarsspecif
tabl
potenti
biomark
found
significantli
associ
sarscov
viral
load
correl
sarscov
rna
acutephas
reaction
correl
creactiv
protein
crp
lung
damag
correl
lactat
dehydrogenas
ld
liver
function
correl
albumin
andor
total
protein
immun
respons
correl
neutrophil
count
correl
total
leukocyt
count
age
correl
respect
thu
biomark
could
reflect
differ
physiolog
condit
bodi
infect
sarscov
dendrogram
fig
major
sar
case
group
cluster
significantli
case
poor
prognosi
requir
treatment
intens
care
unit
icu
andor
supplement
oxygen
treatment
sar
cluster
area
roc
curv
sarsspecif
proteom
featur
biomark
mz
gave
largest
roc
curv
area
biomark
mz
roc
curv
area
confid
interv
fig
specif
sensit
biomark
mz
roc
curv
area
intens
confid
interv
fig
specif
sensit
attempt
made
purifi
identifi
biomark
highest
diagnost
valu
biomark
correl
viral
load
ceram
bead
captur
proteom
featur
similar
proteinchip
array
protein
elut
ceram
bead
separ
concentr
protein
spot
gel
electrophoresi
success
identifi
protein
spot
mass
correspond
proteom
featur
mz
valu
intern
fragment
fibrinogen
chain
immunoglobulin
light
chain
ntermin
fragment
complement
respect
fig
studi
demonstr
seldi
proteinchip
technolog
identifi
serum
protein
protein
fragment
differenti
regul
adult
sar
patient
avoid
identif
fals
signific
differenti
proteom
featur
use
datamin
strategi
similar
use
previou
studi
consid
differenti
proteom
featur
correl
least
biochemicalclin
featur
consid
sarsspecif
strategi
adopt
ensur
identifi
diseasespecif
proteom
featur
biolog
mean
product
systemat
bia
success
identifi
potenti
biomark
reflect
variou
physiolog
patholog
respons
bodi
sar
infect
includ
acutephas
reaction
lung
damag
impair
liver
function
neutrophil
activ
viral
load
sensit
marker
proteom
featur
mz
neg
correl
neutrophil
count
largest
chest
radiograph
chang
found
intern
fragment
fibrinogen
chain
one
hand
previous
report
high
neutrophil
count
risk
factor
associ
clinic
deterior
sar
hand
intravascular
fibrin
deposit
observ
sar
patient
vascular
fibrin
thrombi
often
associ
pulmonari
infarct
specif
interact
neutrophil
fibrin
thrombi
well
recogn
addit
neutrophil
produc
neutral
proteas
cleav
fibrinogen
peptid
fragment
possibl
fibrinogen
andor
fragment
involv
pathophysiolog
mechan
link
neutrophil
activ
lung
damag
next
sensit
biomark
proteom
featur
mz
featur
identifi
ntermin
fragment
complement
complement
compos
chain
mr
chain
mr
central
molecul
complement
system
compris
classic
altern
lectin
pathway
activ
subsequ
inactiv
sever
physiolog
protein
fragment
produc
examin
sodium
dodecyl
gel
electrophoresi
separ
mr
fragment
mr
ntermin
fragment
mr
ctermin
fragment
presenc
free
ntermin
fragment
blood
circul
might
result
degrad
sar
patient
concentr
fragment
posit
correl
crp
suggest
posit
associ
acutephas
reaction
activ
complement
system
worth
noth
fragment
contain
bind
domain
complement
receptor
type
activ
complement
receptor
type
enhanc
phagocytosi
neutrophil
activ
bcell
differenti
date
inform
activ
complement
pathway
sar
patient
limit
liao
et
al
report
signific
differ
concentr
sar
control
patient
anoth
group
demonstr
sarscov
could
trigger
complement
activ
lectin
pathway
biolog
relev
sar
remain
unknown
proteom
featur
mz
increas
sar
patient
posit
correl
viral
load
found
immunoglobulin
light
chain
find
consist
recent
find
antisarscov
igg
sar
case
time
sampl
igg
first
detect
day
ill
higher
igg
concentr
detect
patient
poor
outcom
ie
requir
supplement
oxygen
hypoxia
treatment
icu
asid
use
individu
differenti
proteom
featur
biomark
one
could
combin
differenti
featur
form
sarsspecif
fingerprint
sarsspecif
fingerprint
could
differenti
sar
nonsar
diseas
similar
symptom
also
could
use
identifi
patient
poor
prognosi
prognost
capabl
could
explain
fact
identifi
differenti
proteom
featur
correl
clinic
biochem
featur
prognost
valu
includ
viral
load
neutrophil
count
ld
age
previous
research
team
use
seldi
proteinchip
technolog
report
potenti
biomark
sera
adult
sar
patient
present
studi
intens
proteom
featur
mz
significantli
lower
sar
patient
test
p
studi
yip
et
al
also
report
significantli
lower
sar
patient
test
p
except
proteom
featur
sarsassoci
proteom
featur
studi
differ
find
differ
might
attribut
differ
select
criteria
control
previou
studi
control
case
either
healthi
person
person
viral
infect
clinic
extent
similar
symptom
sar
control
group
time
point
blood
collect
consid
present
studi
control
group
compris
suspect
sar
patient
admit
hospit
sar
patient
later
shown
neg
sarscov
infect
symptom
sar
control
group
time
point
blood
collect
similar
biomark
identifi
present
studi
may
thu
advantag
actual
diagnost
set
compar
identifi
previou
studi
differ
find
report
yip
et
al
present
studi
could
also
attribut
use
differ
profil
methodolog
studi
yip
et
al
use
comprehens
profil
approach
denatur
urea
deterg
serum
protein
first
fraction
anionexchang
bead
give
fraction
later
analyz
copper
proteinchip
array
weak
cationexchang
proteinchip
array
use
comprehens
profil
approach
would
increas
chanc
identif
potenti
protein
marker
present
studi
analyz
serum
protein
directli
purif
proteinchip
array
differ
bind
condit
ph
ph
chose
proteinchip
array
previous
call
kang
et
al
show
chip
type
give
best
profil
result
analyz
serum
sampl
sar
patient
direct
bind
approach
although
direct
bind
approach
might
lead
discoveri
fewer
biomark
direct
bind
assay
higher
potenti
modifi
use
clinic
assay
use
even
protein
ident
diseasespecif
seldi
peak
known
commonli
use
assay
detect
sar
base
detect
viral
rna
antibodi
sarscov
detect
viral
rna
use
earli
phase
diseas
wherea
serolog
test
antibodi
sarscov
use
day
onward
current
studi
demonstr
within
first
week
onset
fever
similar
viral
rna
concentr
serum
proteom
contain
diagnost
prognost
inform
seldi
proteinchip
assay
could
use
firstlin
detect
sar
follow
quantit
viral
rna
assay
confirm
diseas
confirm
treatment
strategi
could
adjust
accord
prognosi
base
seldi
proteinchip
profil
result
viral
rna
concentr
conclus
demonstr
diseasespecif
proteom
fingerprint
present
sera
adult
sar
patient
could
use
identifi
sar
case
earli
stage
diseas
high
specif
sensit
marker
may
provid
inform
patient
physiolog
statu
well
prognost
inform
proteom
featur
highest
diagnost
valu
ntermin
fragment
complement
intern
fragment
fibrinogen
chain
proteom
featur
mz
posit
correl
viral
load
identifi
immunoglobulin
light
chain
abbrevi
sar
sever
acut
respiratori
syndrom
cov
coronaviru
seldi
surfaceenhanc
laser
desorptionion
sam
signific
analysi
microarray
msm
tandem
mass
spectrometri
crp
creactiv
protein
ld
lactat
dehydrogenas
icu
intens
care
unit
